OncoSGS™ contains a specially cultivated form of broccoli seed known as BroccoRaphanin™. This proprietary and patented variety of broccoli, Brassica Oleracea italica, is particularly rich in glucoraphanin (better known as sulforaphane glucosinolate). Sulforaphane glucosinolate is the direct precursor to sulforaphane. Sulforaphane is part of a family of compounds collectively known as isothiocyanates. Sulforaphane was isolated and identified by researchers in 1992.
There are currently over 500 journal publications, as well as documented epidemiological evidence, showing that diets rich in broccoli and broccoli sprouts are chemoprotective and may reduce the risk of many forms of cancer. Scientists also believe that sulforaphane glucosinolate may boost the body’s own antioxidant defense system, including the upregulation of phase 2 detoxification enzymes. For this reason, it is often referred to as an “indirect antioxidant”. The phase 2 enzymes that are induced demonstrate broad-spectrum antioxidant ability, which may remain active in the body for as long as 96 hours. Sulforaphane glucosinolate is also particularly useful in the fact that it upregulates phase 2 enzymes without upregulating the potentially pro-carcinogen-producing phase 1 enzymes.As a dietary supplement, take one capsule daily with water or as directed by your health care practitioner.wheat, yeast, soy, gluten, eggs, dairy, corn, artificial colors, flavors, sugars, or preservatives.BroccoRaphanin® is a registered trademark of CS Health.